CNTA
Price
$29.03
Change
+$0.05 (+0.17%)
Updated
Nov 28 closing price
Capitalization
4.29B
117 days until earnings call
Intraday BUY SELL Signals
LRMR
Price
$3.54
Change
+$0.01 (+0.28%)
Updated
Nov 28 closing price
Capitalization
302.99M
108 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTA vs LRMR

Header iconCNTA vs LRMR Comparison
Open Charts CNTA vs LRMRBanner chart's image
Centessa Pharmaceuticals
Price$29.03
Change+$0.05 (+0.17%)
Volume$1.22M
Capitalization4.29B
Larimar Therapeutics
Price$3.54
Change+$0.01 (+0.28%)
Volume$813.82K
Capitalization302.99M
CNTA vs LRMR Comparison Chart in %
CNTA
Daily Signal:
Gain/Loss:
LRMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CNTA vs. LRMR commentary
Nov 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a StrongBuy and LRMR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 30, 2025
Stock price -- (CNTA: $29.03 vs. LRMR: $3.54)
Brand notoriety: CNTA and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 76% vs. LRMR: 27%
Market capitalization -- CNTA: $4.29B vs. LRMR: $302.99M
CNTA [@Biotechnology] is valued at $4.29B. LRMR’s [@Biotechnology] market capitalization is $302.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, both CNTA and LRMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 4 TA indicator(s) are bullish while LRMR’s TA Score has 5 bullish TA indicator(s).

  • CNTA’s TA Score: 4 bullish, 4 bearish.
  • LRMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CNTA and LRMR are a good buy in the short-term.

Price Growth

CNTA (@Biotechnology) experienced а +3.75% price change this week, while LRMR (@Biotechnology) price change was -0.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

CNTA is expected to report earnings on Mar 26, 2026.

LRMR is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($4.29B) has a higher market cap than LRMR($303M). CNTA YTD gains are higher at: 73.313 vs. LRMR (-8.527). LRMR has higher annual earnings (EBITDA): -108.21M vs. CNTA (-214.83M). CNTA has more cash in the bank: 251M vs. LRMR (139M). LRMR has less debt than CNTA: LRMR (4.61M) vs CNTA (118M). CNTA has higher revenues than LRMR: CNTA (15M) vs LRMR (0).
CNTALRMRCNTA / LRMR
Capitalization4.29B303M1,416%
EBITDA-214.83M-108.21M199%
Gain YTD73.313-8.527-860%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash251M139M181%
Total Debt118M4.61M2,557%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTALRMR
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 17 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CNTA
Daily Signal:
Gain/Loss:
LRMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLPZX19.41N/A
N/A
JPMorgan US Large Cap Core Plus R2
FSMDX37.13N/A
N/A
Fidelity Mid Cap Index
TRACX18.62N/A
N/A
PGIM Quant Solutions Small-Cap Val C
SMNAX27.29N/A
N/A
Steward Equity Market Neutral A
LVOQX17.50N/A
N/A
Lord Abbett Value Opportunities R2

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with CLDX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
+0.17%
CLDX - CNTA
42%
Loosely correlated
+0.86%
RVMD - CNTA
40%
Loosely correlated
+0.23%
ROIV - CNTA
40%
Loosely correlated
-0.29%
VRDN - CNTA
39%
Loosely correlated
+0.76%
CGON - CNTA
39%
Loosely correlated
N/A
More